Doi.org/10.1038/bjc.2014.72
Revision as of 00:22, 4 August 2022 by 179.215.124.0 (talk) (Created page with "== Target Article == Clinical Significance of p95HER2 Overexpression, PTEN Loss and PI3K Expression in p185HER2-positive Metastatic Breast Cancer Patients Treated with Trastuzumab-based Therapies ; Deniz Tural Suheyla Serdengecti Fuat Demirelli Tulin Ozturk Sennur Ilvan Handa Turna Mustafa O; NULL; 04/15/2014; https://doi.org/10.1038/bjc.2014.72 == Reasons == Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.")
Target ArticleEdit
Clinical Significance of p95HER2 Overexpression, PTEN Loss and PI3K Expression in p185HER2-positive Metastatic Breast Cancer Patients Treated with Trastuzumab-based Therapies ; Deniz Tural Suheyla Serdengecti Fuat Demirelli Tulin Ozturk Sennur Ilvan Handa Turna Mustafa O; NULL; 04/15/2014; https://doi.org/10.1038/bjc.2014.72
ReasonsEdit
Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.